These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7327451)

  • 21. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.
    Apperley E; Feniuk W; Humphrey PP; Levy GP
    Br J Pharmacol; 1980 Feb; 68(2):215-24. PubMed ID: 7357206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of endothelium on glyceryl trinitrate induced relaxation in corresponding arteries and veins of the rabbit.
    Rösen R; Horn-Bosbach M; König E; Klaus W
    Z Kardiol; 1989; 78 Suppl 2():29-32; discussion 64-7. PubMed ID: 2511689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the 5-HT receptor in vascular smooth muscle.
    Müller-Schweinitzer E
    Res Clin Stud Headache; 1978; 6():6-12. PubMed ID: 725257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
    Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nitrate ester ITF 296 relaxes isolated canine arteries and veins.
    Desta B; Nakashima M; Vanhoutte PM; Boulanger CM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S53-8. PubMed ID: 8839227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modifications of canine vascular smooth muscle responses to dihydroergotamine by endogenous prostaglandin synthesis.
    MULLER-Schweinitzer E; Brundell J
    Eur J Pharmacol; 1975 Nov; 34(1):197-206. PubMed ID: 1234762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibitory effect of neomycin on contractile responses of various canine arteries.
    Adams HR; Goodman FR
    J Pharmacol Exp Ther; 1975 May; 193(2):393-402. PubMed ID: 1142097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturational changes in the pharmacological characteristics and actomyosin content of canine arterial and venous tissue.
    Seidel CL; Ross B; Michael L; Freedman J; Burdick B; Miller T
    Pediatr Res; 1987 Feb; 21(2):152-8. PubMed ID: 3822594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM; Vanhoutte PM
    Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes.
    Magnon M; Gallix P; Cavero I
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thrombin on isolated canine blood vessels.
    Janssens WJ; Verhaeghe RH
    Blood Vessels; 1982; 19(3):126-34. PubMed ID: 7074226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional differences in the responsiveness of isolated arteries from cattle, dog and man.
    Müller-Schweinitzer E; Weidmann H
    Agents Actions; 1977 Sep; 7(3):383-9. PubMed ID: 596322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta-aescin extract from Chinese buckeye seed on chronic venous insufficiency.
    Yu Z; Su P
    Pharmazie; 2013 Jun; 68(6):428-30. PubMed ID: 23875249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
    Stürmer E
    Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E
    Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the peripheral mode of action of dihydroergotamine in human and canine veins.
    Müller-Schweinitzer E
    Eur J Pharmacol; 1974 Jul; 27(2):231-7. PubMed ID: 4854492
    [No Abstract]   [Full Text] [Related]  

  • 39. Altered responsiveness of saphenous vein grafts to norepinephrine and tyramine: relation to tissue catecholamine stores.
    Soliman AS; Tackett RL
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):154-7. PubMed ID: 1708049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.
    Müller-Schweinitzer E
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1455-60. PubMed ID: 2127899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.